PHBB.F logo

Pharmaron Beijing OTCPK:PHBB.F Stock Report

Last Price

US$1.93

Market Cap

US$4.7b

7D

0%

1Y

n/a

Updated

11 Aug, 2024

Data

Company Financials +

Pharmaron Beijing Co., Ltd.

OTCPK:PHBB.F Stock Report

Market Cap: US$4.7b

PHBB.F Stock Overview

Provides drug research and development, and production services to the life sciences industry in North America, Europe, Japan, Mainland China, and internationally. More details

PHBB.F fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance3/6
Financial Health5/6
Dividends1/6

Pharmaron Beijing Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Pharmaron Beijing
Historical stock prices
Current Share PriceCN¥1.93
52 Week HighCN¥2.25
52 Week LowCN¥1.93
Beta0.65
11 Month Change0%
3 Month Changen/a
1 Year Changen/a
33 Year Changen/a
5 Year Changen/a
Change since IPO-14.22%

Recent News & Updates

Recent updates

Shareholder Returns

PHBB.FUS Life SciencesUS Market
7D0%2.8%2.2%
1Yn/a2.9%31.6%

Return vs Industry: Insufficient data to determine how PHBB.F performed against the US Life Sciences industry.

Return vs Market: Insufficient data to determine how PHBB.F performed against the US Market.

Price Volatility

Is PHBB.F's price volatile compared to industry and market?
PHBB.F volatility
PHBB.F Average Weekly Movementn/a
Life Sciences Industry Average Movement8.5%
Market Average Movement6.3%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market3.1%

Stable Share Price: PHBB.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine PHBB.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
200420,295Boliang Louwww.pharmaron.com

Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides drug research and development, and production services to the life sciences industry in North America, Europe, Japan, Mainland China, and internationally. The company offers laboratory chemistry services, including medicinal and synthetic chemistry, chemistry for new modalities, radiolabelling and radiosynthesis, analytical and purification chemistry, DNA-encoded libraries, cheminformatics, and computer-aided drug design; bioscience services, such as structural biology, in vitro biology, DMPK, in vivo pharmacology, and compound management services; chemistry, manufacturing, and controls services. It also provides clinical development services, including integrated radio labelled science, clinical development, and clinical trial recruitment services; safety assessment, integrated drug discovery, and bioanalysis services; and biologics and cell and gene therapy services, comprising biologics laboratory, biologics CDMO, cell and gene therapy laboratory, and gene therapy CDMO services.

Pharmaron Beijing Co., Ltd. Fundamentals Summary

How do Pharmaron Beijing's earnings and revenue compare to its market cap?
PHBB.F fundamental statistics
Market capUS$4.67b
Earnings (TTM)US$207.01m
Revenue (TTM)US$1.60b

25.1x

P/E Ratio

3.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PHBB.F income statement (TTM)
RevenueCN¥11.48b
Cost of RevenueCN¥7.47b
Gross ProfitCN¥4.01b
Other ExpensesCN¥2.53b
EarningsCN¥1.48b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 28, 2024

Earnings per share (EPS)0.83
Gross Margin34.94%
Net Profit Margin12.92%
Debt/Equity Ratio58.3%

How did PHBB.F perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

24%

Payout Ratio